APGE Earnings Apogee Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -1.06 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -4.22 | 2026-03-02 | 10-K |
| Q3 2025 | 2025-09-30 | -3.19 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.08 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.95 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -3.30 | 2026-03-02 | 10-K |
| Q3 2025 | 2024-09-30 | -2.11 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.24 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.64 | 2025-05-12 | 10-Q |
| FY 2025 | 2023-12-31 | -3.36 | 2026-03-02 | 10-K |
| Q3 2024 | 2023-09-30 | -3.04 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -6.28 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -2.51 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -16.16 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -17.00 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -5.25 | 2023-08-28 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.